Open access
271
Views
25
CrossRef citations to date
0
Altmetric
Review
Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis
Michael Hinchcliffe1 Paracelsis Ltd, [email protected]Correspondence[email protected]
& Alan Smith2 PharmaSci Consulting Ltd, Nottingham, UK
Pages 61-70
|
Published online: 29 May 2017
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.